PFAS Testing Market (2026-2036)

The growth of this market is mainly driven by enforceable drinking water limits and monitoring requirements in the U.S., the EU, and other regions, environmental liability and remediation obligations for contaminated sites, expanding restrictions on PFAS in consumer products and packaging, and major PFAS litigation that has increased corporate testing and due diligence. However, regulatory uncertainty and partial rollbacks, the high cost and limited capacity of ultra-trace analysis, gaps in validated methods and reference standards for thousands of PFAS, and the risk of sample contamination restrain the growth of this market.

Furthermore, total organic fluorine screening, non-targeted high-resolution analysis, and product and supply chain testing are expected to offer growth opportunities for the stakeholders in this market. However, shortages of skilled analytical chemists, the comparability of data across methods, turnaround time and sample logistics, and funding constraints for small water systems remain major challenges impacting the growth of this market. Additionally, the shift from compound-specific to class-based PFAS measurement, laboratory consolidation and capacity expansion, automation and high-throughput sample preparation, and the growth of wastewater and biosolids testing are prominent trends in this market.

The PFAS Testing Market comprises the analytical services, instruments, consumables, reference standards, and software used to detect and quantify per- and polyfluoroalkyl substances, a family of thousands of highly persistent synthetic chemicals known as forever chemicals, in environmental, food, product, and biological samples. The market covers targeted liquid chromatography with tandem mass spectrometry for specific PFAS, high-resolution mass spectrometry for suspect and non-targeted analysis, total organic fluorine methods such as adsorbable and extractable organic fluorine by combustion ion chromatography, the total oxidizable precursor assay, gas chromatography-mass spectrometry for volatile PFAS, and rapid screening technologies. Sample matrices include drinking water, groundwater and surface water, wastewater and landfill leachate, soil, sediment and biosolids, food and beverages, consumer products and packaging, biological samples such as serum and tissue, and air and stack emissions. Market value is measured at revenue from testing services and sales of instruments, consumables, standards, and software attributable to PFAS analysis. The ecosystem spans commercial and government laboratories, instrument and consumables manufacturers, reference standard producers, water utilities, environmental consultants, industrial and consumer goods companies, regulators, and litigants.

Drinking water regulation is the market's foundation. In April 2024, the U.S. EPA issued the first enforceable National Primary Drinking Water Regulation for PFAS, setting maximum contaminant levels of 4.0 parts per trillion for PFOA and PFOS and 10 parts per trillion for PFHxS, PFNA, and HFPO-DA, known as GenX chemicals, plus a hazard index for mixtures, and requiring public water systems to complete initial monitoring by 2027 and comply by April 2029. In May 2025, EPA announced it would retain the PFOA and PFOS limits while extending compliance to 2031 and rescinding the other limits, and in May 2026 it published proposed rules to implement these changes, providing an exemption pathway to April 2031 for qualifying systems, requiring short-term mitigation for systems at or above 12 parts per trillion, and keeping monitoring and reporting requirements on the 2024 timelines. Detecting PFAS at single-digit parts per trillion requires highly sensitive instruments, rigorous contamination control, and specialized laboratories.

Regulation is expanding beyond drinking water and beyond the U.S. The EU's recast Drinking Water Directive applies PFAS limits from January 2026, of 0.1 micrograms per liter for the sum of 20 PFAS and 0.5 micrograms per liter for total PFAS, and the European Chemicals Agency is evaluating a proposal to restrict the manufacture and use of thousands of PFAS, while the EU's Packaging and Packaging Waste Regulation restricts PFAS in food contact packaging and France and Denmark have adopted national restrictions on PFAS in consumer products. In the U.S., EPA Method 1633, finalized in 2024, enables measurement of 40 PFAS in wastewater, soil, biosolids, and tissue, and states such as Minnesota and Maine have restricted PFAS in consumer products. Canada has set a drinking water objective for the sum of 25 PFAS, and Japan and Australia have strengthened PFAS guidelines.

Liability and litigation add to demand. In 2024, EPA designated PFOA and PFOS as hazardous substances under the U.S. Superfund law, increasing site investigation and cleanup obligations, and major settlements, including 3M's settlement with U.S. public water systems valued at USD 10.3 billion to USD 12.5 billion and a settlement by DuPont, Chemours, and Corteva of about USD 1.185 billion in 2023, have required water systems and companies to test extensively. At the same time, the market faces constraints, including regulatory uncertainty, the cost of ultra-trace analysis, and the lack of methods and standards for most of the thousands of PFAS, which are driving adoption of class-based methods such as total organic fluorine.